Top

Published in:

01-04-2013 | Genitourinary Infections (J Sobel, Section Editor)

Prevention and Treatment of Urinary Catheter-Associated Infections

Authors: Mayar Al Mohajer, Rabih O. Darouiche

Published in: Current Infectious Disease Reports | Issue 2/2013

Abstract

Catheter-associated urinary tract infections (CA-UTIs) are the most common nosocomial infection worldwide. Prolonged catheterization is the most important risk factor for CA-UTIs. As is the case with all device-related infections, the biofilm plays a central role in the pathogenesis of CA-UTIs. The diagnosis is often difficult, given the lack of good diagnostic tests. The most effective way to prevent infection is to limit catheter use and discontinue the catheter when no longer needed. Catheter removal or exchange is also useful in management. This review summarizes and analyzes the results of published studies of CA-UTIs and assesses the role of prevention approaches and management strategies.

Weinstein RA. Health-care associated infections. In: Kasper DL, Fauci AS, editors. Harrison’s infectious diseases. China: McGraw-Hill Companies Inc; 2010. p. 144–53.

•• Siddiq DM, Darouiche RO. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 2012;9(6):305–14. This article provides important information on the prevention of CA-UTI.PubMedCrossRef

Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008;29(9):785–814.PubMedCrossRef

Hooton TM. Nosocomial Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s principles and practice of infectious diseases, vol. 2. 7th ed. Philadelphia: Elsevier Inc; 2010. p. 3725–37.CrossRef

Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981;70(4):947–59.PubMedCrossRef

•• Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63. These guidelines provide very important information on prevention and management of CA-UTI.PubMedCrossRef

Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am. 2012;26(1):13–27.PubMedCrossRef

Nicolle LE. Catheter-related urinary tract infection. Drugs Aging. 2005;22(8):627–39.PubMedCrossRef

Warren JW, Tenney JH, Hoopes JM, et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146(6):719–23.PubMedCrossRef

10.

Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003;17(2):411–32.PubMedCrossRef

11.

Jacobsen SM, Stickler DJ, Mobley HL, et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26–59.PubMedCrossRef

12.

Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7(2):342–7.PubMedCrossRef

13.

Garibaldi RA, Burke JP, Dickman ML, et al. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974;291(5):215–9.PubMedCrossRef

14.

Garibaldi RA, Burke JP, Britt MR, et al. Meatal colonization and catheter-associated bacteriuria. N Engl J Med. 1980;303(6):316–8.PubMedCrossRef

15.

Platt R, Polk BF, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986;124(6):977–85.PubMed

16.

Bakke A, Digranes A, Høisaeter PA. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol. 1997;79(1):85–90.PubMedCrossRef

17.

Bakke A, Vollset SE. Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. J Urol. 1993;149(3):527–31.PubMed

18.

Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160(5):678–82.PubMedCrossRef

19.

Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–54.PubMedCrossRef

20.

Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev. 2007;2:CD004011.PubMed

21.

Phipps S, Lim YN, McClinton S, et al. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev. 2006;2:CD004374.PubMed

22.

Gokula RR, Hickner JA, Smith MA. Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital. Am J Infect Control. 2004;32(4):196–9.PubMedCrossRef

23.

Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control. 1982;3(6):466–70.PubMed

24.

Goetz AM, Kedzuf S, Wagener M, et al. Feedback to nursing staff as an intervention to reduce catheter-associated urinary tract infections. Am J Infect Control. 1999;27(5):402–4.PubMedCrossRef

25.

Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25(1):47–50.PubMedCrossRef

26.

Apisarnthanarak A, Thongphubeth K, Sirinvaravong S, et al. Effectiveness of multifaceted hospitalwide quality improvement programs featuring an intervention to remove unnecessary urinary catheters at a tertiary care center in Thailand. Infect Control Hosp Epidemiol. 2007;28(7):791–8.PubMedCrossRef

27.

• Bruminhent J, Keegan M, Lakhani A, et al. Effectiveness of a simple intervention for prevention of catheter-associated urinary tract infections in a community teaching hospital. Am J Infect Control. 2010;38(9):689–93. This article provides important information on the use of reminder stickers in preventing CA-UTI.PubMedCrossRef

28.

Blodgett TJ. Reminder systems to reduce the duration of indwelling urinary catheters: a narrative review. Urol Nurs. 2009;29(5):369–78. quiz 379.PubMed

29.

Meddings J, Rogers MA, Macy M, et al. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550–60.PubMedCrossRef

30.

Saint S, Kaufman SR, Rogers MA, et al. Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc. 2006;54(7):1055–61.PubMedCrossRef

31.

Niël-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005;3:CD004203.PubMed

32.

Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74(2):131–6.PubMedCrossRef

33.

Carapeti EA, Andrews SM, Bentley PG. Randomised study of sterile versus non-sterile urethral catheterisation. Ann R Coll Surg Engl. 1996;78(1):59–60.PubMed

34.

Lo E, Nicolle L, Classen D, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S41–50.PubMedCrossRef

35.

Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Phys. 1956;69:56–64.PubMed

36.

Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274(21):1155–61.PubMedCrossRef

37.

Rutala WA, Kennedy VA, Loflin HB, et al. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med. 1981;70(3):659–63.PubMedCrossRef

38.

Crnich CJ, Drinka PJ. Does the composition of urinary catheters influence clinical outcomes and the results of research studies? Infect Control Hosp Epidemiol. 2007;28(1):102–3.PubMedCrossRef

39.

Srinivasan A, Karchmer T, Richards A, et al. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 2006;27(1):38–43.PubMedCrossRef

40.

Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med. 2007;147(5):285–93.PubMed

41.

Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2008;2:CD004013.PubMed

42.

Pickard R, Lam T, Maclennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012 Nov 2.

43.

Seymour C. Audit of catheter-associated UTI using silver alloy-coated Foley catheters. Br J Nurs. 2006;15(11):598–603.PubMed

44.

Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32(8):445–50.PubMedCrossRef

45.

Lee SJ, Kim SW, Cho YH, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Agents. 2004;24 Suppl 1:S65–9.PubMedCrossRef

46.

Al-Habdan I, Sadat-Ali M, Corea JR, et al. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg. 2003;88(3):152–4.PubMed

47.

Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30(4):221–5.PubMedCrossRef

48.

Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol. 2002;23(4):217–8.PubMedCrossRef

49.

Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160(21):3294–8.PubMedCrossRef

50.

Thibon P, Le Coutour X, Leroyer R, et al. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect. 2000;45(2):117–24.PubMedCrossRef

51.

Bologna RA, Tu LM, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54(6):982–7.PubMedCrossRef

52.

Verleyen P, De Ridder D, Van Poppel H, et al. Clinical application of the Bardex IC Foley catheter. Eur Urol. 1999;36(3):240–6.PubMedCrossRef

53.

Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol. 1990;17(3):236–40.PubMed

54.

Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65(4):379–81.PubMedCrossRef

55.

Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999;159(8):800–8.PubMedCrossRef

56.

Petronella P, Scorzelli M, Fiore A, et al. Antibiotic prophylaxis in catheter-associated urinary infections. New Microbiol. 2012;35(2):191–8.PubMed

57.

Rutschmann OT, Zwahlen A, et al. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients. Eur J Clin Microbiol Infect Dis. 1995;14(5):441–4.PubMedCrossRef

58.

Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med. 1993;95(2):141–52.PubMedCrossRef

59.

•• Darouiche RO, Hull RA. Bacterial interference for prevention of urinary tract infection. Clin Infect Dis. 2012;55(10):1400–7. This article provides very important information on the use of bacterial interference for preventing catheter-related urinary tract infections.PubMedCrossRef

60.

Hull RA, Rudy DC, Donovan WH, et al. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun. 1999;67(1):429–32.PubMed

61.

Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6.PubMedCrossRef

62.

Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000;30(1):19–24.PubMedCrossRef

63.

• Trautner BW. Management of catheter-associated urinary tract infection. Curr Opin Infect Dis. 2010;23(1):76–82. This article provide important information on the management of CA-UTI and medicare rule changes in the USA.PubMedCrossRef

64.

Leone M, Perrin AS, Granier I, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med. 2007;33(4):726–9.PubMedCrossRef

65.

Warren JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982;248(4):454–8.PubMedCrossRef

66.

Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol. 1984;132(5):943–6.PubMed

67.

Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329(18):1328–34.PubMedCrossRef

68.

Bergqvist D, Brönnestam R, Hedelin H, et al. The relevance of urinary sampling methods in patients with indwelling Foley catheters. Br J Urol. 1980;52(2):92–5.PubMedCrossRef

69.

Tenney JH, Warren JW. Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis. 1988;157(1):199–202.PubMedCrossRef

70.

Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164(4):1254–8.PubMedCrossRef

71.

Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008;71(1):17–22.PubMedCrossRef

Title: Prevention and Treatment of Urinary Catheter-Associated Infections
Authors: Mayar Al Mohajer
Rabih O. Darouiche
Publication date: 01-04-2013
Publisher: Current Science Inc.
Published in: Current Infectious Disease Reports / Issue 2/2013
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-013-0316-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Alternative Approaches to Conventional Treatment of Acute Uncomplicated Urinary Tract Infection in Women

Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia

Epidemiologic and Clinical Implications of Second-Generation Pneumococcal Conjugate Vaccines

Mixed Vaginitis—More Than Coinfection and With Therapeutic Implications

Could Vitamin D Have a Potential Anti-Inflammatory and Anti-Infective Role in Bronchiectasis?

Hospital Admission Decision for Patients with Community-Acquired Pneumonia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials